Author details

Full Name

Nilsa C Ramirez

Affiliation

ORCID

Career Start Year

1989

Papers

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
37523711	The Cooperative Human Tissue Network of the National Cancer Institute: Supporting Cancer Research for 35 Years.		2023
37228094	Tazemetostat for tumors harboring SMARCB1/SMARCA4 or EZH2 alterations: results from NCI-COG pediatric MATCH APEC1621C.	J Natl Cancer Inst	2023
34224438	Effects of Slide Storage on Detection of Molecular Markers by IHC and FISH in Endometrial Cancer Tissues From a Clinical Trial: An NRG Oncology/GOG Pilot Study.	Applied Immunohistochemistry and Molecular Morphology	2022
36077609	Improving Risk Assessment for Metastatic Disease in Endometrioid Endometrial Cancer Patients Using Molecular and Clinical Features: An NRG Oncology/Gynecologic Oncology Group Study.	Cancers (Basel)	2022
35617957	Genetic changes associated with relapse in favorable histology Wilms tumor: A Children's Oncology Group AREN03B2 study.	Cell Rep Med	2022
35363510	Phase II Study of Selumetinib in Children and Young Adults With Tumors Harboring Activating Mitogen-Activated Protein Kinase Pathway Genetic Alterations: Arm E of the NCI-COG Pediatric MATCH Trial.	J Clin Oncol	2022
35353553	Actionable Tumor Alterations and Treatment Protocol Enrollment of Pediatric and Young Adult Patients With Refractory Cancers in the National Cancer Institute-Children's Oncology Group Pediatric MATCH Trial.	J Clin Oncol	2022
34319759	Revised Neuroblastoma Risk Classification System: A Report From the Children's Oncology Group.	J Clin Oncol	2021
33622671	Sex Hormones, Insulin, and Insulin-like Growth Factors in Recurrence of High-Stage Endometrial Cancer.	Cancer Epidemiol Biomarkers Prev	2021
31613330	Toward Improving Practices for Submission of Diagnostic Tissue Blocks for National Cancer Institute Clinical Trials.	Am J Clin Pathol	2020
29191972	Mutations in Homologous Recombination Genes and Outcomes in Ovarian Carcinoma Patients in GOG 218: An NRG Oncology/Gynecologic Oncology Group Study.	Clin Cancer Res	2018
29394087	The College of American Pathologists Biorepository Accreditation Program: Results from the First 5 Years.	Biopreserv Biobank	2018
29394084	Standardization and Innovation in Paving a Path to a Better Future: An Update of Activities in ISO/TC276/WG2 Biobanks and Bioresources.	Biopreserv Biobank	2018
29132872	An NRG Oncology/GOG study of molecular classification for risk prediction in endometrioid endometrial cancer.	Gynecol Oncol	2018
28314589	FGFR2 mutations are associated with poor outcomes in endometrioid endometrial cancer: An NRG Oncology/Gynecologic Oncology Group study.	Gynecologic Oncology	2017
28532857	High stathmin expression is a marker for poor clinical outcome in endometrial cancer: An NRG oncology group/gynecologic oncology group study.	Gynecologic Oncology	2017
28969912	Dysregulation of miR-181c expression influences recurrence of endometrial endometrioid adenocarcinoma by modulating NOTCH2 expression: An NRG Oncology/Gynecologic Oncology Group study.	Gynecologic Oncology	2017
28741961	ISO/TC276/WG2 Biobanks and Bioresources: Draft International Standard Is Now Available for Comment.	Biopreserv Biobank	2017
27926776	Synuclein-Î³ in uterine serous carcinoma impacts survival: An NRG Oncology/Gynecologic Oncology Group study.	Cancer	2017
26536169	Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma.	N Engl J Med	2016
27376138	Summary and Recommendations from the National Cancer Institute's Clinical Trials Planning Meeting on Novel Therapeutics for Non-Muscle Invasive Bladder Cancer.	Bladder Cancer	2016
27325856	Clinicopathologic Significance of Mismatch Repair Defects in Endometrial Cancer: An NRG Oncology/Gynecologic Oncology Group Study.	J Clin Oncol	2016
26720728	Inherited Mutations in Women With Ovarian Carcinoma.	JAMA Oncol	2016
26397159	Expression Patterns of the Wnt Pathway Inhibitors Dickkopf3 and Secreted Frizzled-Related Proteins 1 and 4 in Endometrial Endometrioid Adenocarcinoma: An NRG Oncology/Gynecologic Oncology Group Study.	International Journal of Gynecological Cancer	2016
26603970	The role of racial genetic admixture with endometrial cancer outcomes: An NRG Oncology/Gynecologic Oncology Group study.	Gynecologic Oncology	2016
26144601	Assessing the prognostic role of ATR mutation in endometrioid endometrial cancer: An NRG Oncology/Gynecologic Oncology Group study.	Gynecologic Oncology	2015
26061751	Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas.	N Engl J Med	2015
26552419	Combined Microsatellite Instability, MLH1 Methylation Analysis, and Immunohistochemistry for Lynch Syndrome Screening in Endometrial Cancers From GOG210: An NRG Oncology and Gynecologic Oncology Group Study.	J Clin Oncol	2015
24799092	The effects of frozen tissue storage conditions on the integrity of RNA and protein.	Biotech Histochem	2014
24332040	Targeting oxidative stress in embryonal rhabdomyosarcoma.	Cancer Cell	2013
22246618	Uterine serous carcinoma: increased familial risk for lynch-associated malignancies.	Cancer Prev Res (Phila)	2012
22301415	Elevated cytokine and chemokine levels in the placenta are associated with in-utero HIV-1 mother-to-child transmission.	AIDS	2012
21813170	Cadherins, catenins and cell cycle regulators: impact on survival in a Gynecologic Oncology Group phase II endometrial cancer trial.	Gynecol Oncol	2011
18426735	Diagnosis of hydatidiform moles using p57 immunohistochemistry and HER2 fluorescent in situ hybridization.	Am J Clin Pathol	2008
18057529	Utilizing virtual microscopy for quality control review.	Disease Markers	2007
16676863	Carcinosarcoma of the pancreas arising in a mucinous cystic neoplasm.	American Surgeon	2006
16499956	Advanced endometrial cancer with serous metastasis in a 17-year-old.	Gynecologic Oncology	2006
15578030	Mean arterial pressure in concordant and discordant triplets during the first week of life.	Journal of Perinatology	2005
15738013	Surgical staging for patients presenting with grade 1 endometrial carcinoma.	Obstetrics and Gynecology	2005
15846217	Correlation of cyclooxygenase-2 (COX-2) and aromatase expression in human endometrial cancer: tissue microarray analysis.	American Journal of Obstetrics and Gynecology	2005
15026787	Establishing a tumour bank: banking, informatics and ethics.	Br J Cancer	2004
15581968	Morbid obesity and endometrial cancer: surgical, clinical, and pathologic outcomes in surgically managed patients.	Gynecologic Oncology	2004
14668543	Utility of HPV analysis for evaluation of possible metastatic disease in women with cervical cancer.	International Journal of Gynecological Pathology	2004
15138926	Histologic correlates of viral and bacterial infection of the placenta associated with severe morbidity and mortality in the newborn.	Human Pathology	2004
14675674	Is there a prognostic difference between depth of myometrial invasion and the tumor-free distance from the uterine serosa in endometrial cancer?	Gynecologic Oncology	2003
12376925	Endometrial stromal sarcoma of the retroperitoneum.	Annals of Diagnostic Pathology	2002
10726617	Benign glandular and squamous metaplastic-like cells seen in vaginal Pap smears of post hysterectomy patients: incidence and patient profile.	European Journal of Gynaecological Oncology (discontinued)	2000
10487711	Multiple roles for heparin-binding epidermal growth factor-like growth factor are suggested by its cell-specific expression during the human endometrial cycle and early placentation.	Journal of Clinical Endocrinology and Metabolism	1999
9891243	Ovarian leiomyomas: clinicopathologic features in fifteen cases.	International Journal of Gynecological Pathology	1999
9891242	Ovarian smooth muscle metaplasia: an uncommon and possibly underrecognized entity.	International Journal of Gynecological Pathology	1999